AVR 2.97% $12.15 anteris technologies ltd

Ann: Conclusion of relationship with Go Medical Industries, page-37

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 17,045 Posts.
    lightbulb Created with Sketch. 2414
    Agree. Admedus terminated the agreement because they couldn't get a more competitive price from their manufacturer/supplier. They will look for a new one and carry on. If they didn't they would lose customers. Its unreasonable to think they can't find a better supplier, there are newer and more sophisticated products all the time from other manufacturers.

    All the speculation about losing customer contracts was just nonsense.

    As I recall they forecast was to break even in the last quarter of 2018 and be profitable for 2019. I don't see the statement being that much different...

    Back to more important things.
    Last edited by whytee: 07/06/18
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.